The Pancreas, the Bile Duct, and Beyond: Management With the First FDA-Approved Treatment for IgG4-Related Disease

Highlight expert perspectives on diagnosing IgG4-RD and its manifestations, including type 1 AIP and IgG4-related sclerosing cholangitis. Review Importance of assessing patients with IgG4-RD for extra-GI manifestations and highlight clinical trial data.

Industry Supporter: Amgen